Originally published In Press as doi:10.1074/mcp.M600176-MCP200 on June 7, 2006.
Molecular & Cellular Proteomics 5:1957-1967, 2006.
© 2006 by The American Society for Biochemistry and Molecular Biology, Inc.
Methodologies
Lectin Capture Strategies Combined with Mass Spectrometry for the Discovery of Serum Glycoprotein Biomarkers*
Richard R. Drake ,
E. Ellen Schwegler ,
Gunjan Malik ,
Jose Diaz ,
Timothy Block ,
Anand Mehta and
O. John Semmes ,¶
From the Center for Biomedical Proteomics, Virginia Prostate Center, and Department of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, Norfolk, Virginia 23507 and Drexel Institute of Biotechnology and Virology Research, Doylestown, Pennsylvania 18901
The application of mass spectrometry to identify disease biomarkers in clinical fluids like serum using high throughput protein expression profiling continues to evolve as technology development, clinical study design, and bioinformatics improve. Previous protein expression profiling studies have offered needed insight into issues of technical reproducibility, instrument calibration, sample preparation, study design, and supervised bioinformatic data analysis. In this overview, new strategies to increase the utility of protein expression profiling for clinical biomarker assay development are discussed with an emphasis on utilizing differential lectin-based glycoprotein capture and targeted immunoassays. The carbohydrate binding specificities of different lectins offer a biological affinity approach that complements existing mass spectrometer capabilities and retains automated throughput options. Specific examples using serum samples from prostate cancer and hepatocellular carcinoma subjects are provided along with suggested experimental strategies for integration of lectin-based methods into clinical fluid expression profiling strategies. Our example workflow incorporates the necessity of early validation in biomarker discovery using an immunoaffinity-based targeted analytical approach that integrates well with upstream discovery technologies.
¶ To whom correspondence should be addressed: Dept. of Microbiology and Molecular Cell Biology, Lewis Hall 3144, Eastern Virginia Medical School, Norfolk, VA 23507. Tel.: 757-446-5904; Fax: 757-446-5766; E-mail: semmesoj{at}evms.edu

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Wang, R. E. Long, M. A. Comunale, O. Junaidi, J. Marrero, A. M. Di Bisceglie, T. M. Block, and A. S. Mehta
Novel Fucosylated Biomarkers for the Early Detection of Hepatocellular Carcinoma
Cancer Epidemiol. Biomarkers Prev.,
June 1, 2009;
18(6):
1914 - 1921.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Jia, Z. Lu, Y. Fu, H.-P. Wang, L.-H. Wang, H. Chi, Z.-F. Yuan, Z.-B. Zheng, L.-N. Song, H.-H. Han, et al.
A Strategy for Precise and Large Scale Identification of Core Fucosylated Glycoproteins
Mol. Cell. Proteomics,
May 1, 2009;
8(5):
913 - 923.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kuno, Y. Kato, A. Matsuda, M. K. Kaneko, H. Ito, K. Amano, Y. Chiba, H. Narimatsu, and J. Hirabayashi
Focused Differential Glycan Analysis with the Platform Antibody-assisted Lectin Profiling for Glycan-related Biomarker Verification
Mol. Cell. Proteomics,
January 1, 2009;
8(1):
99 - 108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Mehta, R. E. Long, M. A. Comunale, M. Wang, L. Rodemich, J. Krakover, R. Philip, J. A. Marrero, R. A. Dwek, and T. M. Block
Increased Levels of Galactose-Deficient Anti-Gal Immunoglobulin G in the Sera of Hepatitis C Virus-Infected Individuals with Fibrosis and Cirrhosis
J. Virol.,
February 1, 2008;
82(3):
1259 - 1270.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Harris, H. Fritsche, R. Mennel, L. Norton, P. Ravdin, S. Taube, M. R. Somerfield, D. F. Hayes, and R. C. Bast Jr
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
J. Clin. Oncol.,
November 20, 2007;
25(33):
5287 - 5312.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Gangadharan, R. Antrobus, R. A. Dwek, and N. Zitzmann
Novel Serum Biomarker Candidates for Liver Fibrosis in Hepatitis C Patients
Clin. Chem.,
October 1, 2007;
53(10):
1792 - 1799.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|